News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) Innovates With Equant; Merck KGaA (MKGAF.PK) Signs New Three-Year Agreement For Customized IP VPN Solution


10/19/2005 5:12:30 PM

WASHINGTON & FRANKFURT, Germany--(BUSINESS WIRE)--Dec. 20, 2004--Merck KGaA, the world's first established pharmaceutical and chemicals company, has signed a new three-year agreement with Equant (NYSE: ENT) (Euronext Paris: EQU) to migrate from a legacy network to a 50-site IP VPN solution covering 38 countries.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES